3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Prostatic Neoplasms
14
Breast Neoplasms
12
Multiple Myeloma
8
Neoplasm Metastasis
5
Pain
4
Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Renal Insufficiency
1
Pleural Effusion, Malignant
1
Osteoporosis
1
Osteonecrosis
1
Osteolysis
1
Neoplastic Cells, Circulating
1
Lung Neoplasms
1
Lung Metastases
1
Carcinoma, Renal Cell
1
Bone Neoplasms
1
Bone Diseases, Metabolic
1
Interventions
Pirinitramide
2
Morphine
2
Zoledronic Acid
1
Standard of Care
1
Sevoflurane
1
Propofol
1
Injections, Epidural
1
Ethiodized Oil
1
Epirubicin
1
Diphosphonates
1
Desflurane
1
Chemoembolization, Therapeutic
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Neoplastic Cells, Circulating
×
Zoledronic Acid
×
Clear all
NCT01129336
2014-05-20
MACS1295
Novartis
Phase 4
Completed
44 enrolled
10 charts